Изолированная систолическая артериальная гипертония
Аннотация
В обзоре обсуждаются различные аспекты изолированной систолической артериальной гипертонии (ИСАГ). Представлены общие принципы диагностики и лечения ИСАГ у пожилых и очень пожилых людей.
Об авторах
Л. Г. РатоваРоссия
Тел.: (495) 414-61-86
И. Е. Чазова
Россия
Тел.: (495) 414-61-86
Список литературы
1. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103(9): 1245-9.
2. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the eldery: meta-analysis of outcome trials. Lancet 2000; 355: 865-72.
3. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Комитет экспертов Всероссийского научного общества кардиологов. Секция артериальной гипертонии ВНОК. Москва 2004. Приложение к журналу «Кардиоваскулярная терапия и профилактика».
4. Hypertension: a comparison to Brenner and Rector’s the kidney leading by B.M. Brenneri 5th ed. c. 1996. 2000 by W.B. Sounders Company.
5. Арабидзе Г.Г., Фагард Р., Петров В.В., Стассен Я. Изолированная систолическая гипертония у пожилых. Тер архив 1996; 11: 77-82.
6. Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21: 335-43.
7. Borhani NО. Isolated systolic hypertension in the elderly. J Hypertens 1988; 6(1): 15-9.
8. Kannel WВ, Wolf PA, McGee DL, et al. Systolic blood pressure arterial rigidity and risk of stroke The Framingham study. JAMA 1981; 245: 1225-9.
9. Rutan GH, Kuller LH, Neaton JD, et al. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77: 504-14.
10. Staessen J, Amery A , Fagard R. Isolated systolic hypertension in the elderly. J Hypertension 1990; 8: 393-405.
11. Sleight P. Isolated systolic hypertension: the WISHE study. Eur Heart J 1991; (Suppl.): 17-20.
12. Frishman WH. Epidemiology, pathophysiology, and management of isolated systolic hypertension in the elderly. Am J Med 1991; 90(4B): 14-20.
13. Brandfonbrener M, Landowne M, Shock NW. Changes in cardiac output with age. Circulation 1955; 12: 557-66.
14. Weisfeldt M. Aging changes in the cardiovascular system and responses to sties. Am J Hypertens 1998; 11: 41-5.
15. Simon АС, Levenson JA, Safar ME. Hemodynamic mechanisms of and therapeutic approach to systolic hypertension. J Cardiovasc Pharmacol 1985; 7: 22-7.
16. Delanghe J, Duprez D, De Buyzere M, et al. Haptoglobin polymorphism and hypertension in the elderly. Eur Heart J 1998; 19(Abstr Suppl): 72.
17. Gruchala M, Ciecwierz D, Ochman K, et al. Association between the Pl(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease. Int J Cardiol 2003; 88(24 3): 229-37.
18. Niarchos AP, Laragh JH. Hypertension in the elderly. Mod Concepts Cardiovasc Dis 1980; 49: 43-54.
19. Messerli F. Изолированная систолическая гипертензия. Международные направления в исследовании артериальной гипертензии. Выпуск 2000; 11: 4-6.
20. Staessen J, Bulpitt С, Clement D, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension report of the European Working Party on High Blood Pressure in the Elderly. Br Med J 1989; 298: 1552-6.
21. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-64.
22. Dustan HP. Isolated systolic hypertension a long neglected cause of cardiovascular complications. Am J Med 1989; 86: 368-9.
23. Benetos A, Rudnichi Am, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-4.
24. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-60.
25. Alii С, Avanzmi F, Bettelh G, et al. The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Artenosa nell’Anziano) 10 year follow up. Arch Intern Med 1999; 159: 1205-12.
26. Мартынов А.И., Остроумова О.Д., Ролик И.Л. Артериальная гипертензия у больных пожилого и старческого возpacтa: этиология, клиника, диагностика, лечение. Клин мед 1997; 12: 8-14.
27. Chalmers J, MacMahon S, Anderson С, et al. Blood pressure and stroke prevention. London: Science Press 1996.
28. Kannel WB, Dawber T. Perspectives on systolic hypertension: The Frammingham Study. Circulation 1980; 61: 1179-82.
29. Sagie A, Larson MG, Levy D. The natural history of border line isolated systolic hypertension. New Engl J Med 1993; 329: 1912-7.
30. Weber MA, Neutel JM, Cheung DG. Hypertension in the aged: A pathophysiologic basis for treatment. Am J Cardiol 1989; 63: 25-32.
31. Freis ED for the Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Effects of age on treatment results. Am J Med 1991; 90(3А): 20-3.
32. Medical Research Council Working Party. MRC Trial of Hypertension in Older Adults: Principal results. BMJ 1992; 304: 405-12.
33. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: An overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; I5: 967-78.
34. The Working Group on Hypertension in the Elderly: Statement on hypertension in the elderly. JAMA 1986; 256: 70-4.
35. Neaton JD, Grimm RHJr, Prineas RJ, et al., for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: Final results. JAMA 1993; 270: 713-24.
36. Niarchos AP, Wemstem DL, Laragh JH. Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension. Amer J Med 1984; 77: 1061-8.
37. Safar M, Van Bortel L, Struijker-Boudier H. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Mat Res 1997; 34: 67-81.
38. Girerd X, Giannattasio C, Moulin C, et al. Regression of radial arterial wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. JACC 1998; 31: 1064-73.
39. Ekbom T, Dahlof B, Hansson L, et al. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives a report from the STOP-Hypertension study. J Hypertens 1992; 10: 1525-30.
40. Heesen W, Beltman F, Smit A, et al. Effect of quinapril an triamterene/ hydrochlorothiazide on cardiac and vascular andorgan damage in isolated systolic hypertension. J Cardiovasc Pharmacol 1998; 31: 187-94.
41. Ting C, Chen C, Chang M, Yin F. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance. Hypertension 1995; 26: 524-30.
42. De Cesans R, Ranien G, Filitti V, Andriani A. Large artery com4 pliance in essential hypertension effects of calcium antagonism and beta blocking. Am J Hypertens 1992; 5: 624-8.
43. О ‘Malley К, McCormack P, O’Brien EТ. Isolated systolic hypertension: data from the European Working Party on High Blood Pressere in the Elderly. J Hypertens 1988; 6(1): 105-8.
44. Messerli FH, Grossman E, Goldhourt U. Are b4blockers efficacious as first line therapy for hypertension in the elderly? JAMA 1998; 279: 1903-7.
45. Materson ВJ, Reda DJ, Cushman WС, et al. Department of Veterans Affairs single-drug therapy of hypertension study. Am J Hypertens 1995; 8: 189-92.
46. Ben4Ishay D, Leibel В, Stessman J. Calcium channel blockers in the management of hypertension in the elderly. Am J Med 1986; 81(6A): 30-4.
47. Hansson L. Treatment of elderly hypertensive patients with calcium antagonists. Res clin forums 1994; 16: 61-6.
48. Ратова Л.Г., Чазова И.Е., Беленков Ю.Н. и др. Пожилой человек: жизнь со знаком качества. Болезни сердца и сосудов 2006; 1: 10-5.
49. Trenkwalder P, Hendricks P, Hense HW. Treatment with calcium channel blocker does not increase the risk of fatal and non-fatal cancer in an elderly European population: results from STEPY II. J Hypertens 1998; 16(8): 1113-6.
50. Canter D, Frack G. ACE inhibitors in the treatment of hypertension in the older patient. Eur Heart J 1990; 11(D): 33-43.
51. Schnaper HW. The management of hypertension in older patients. J Cardiovasc Pharmacol 1990; IS(2): 56-61.
52. Gillis JС, Markham A. Irbesartan A review of pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs 1997; 54: 85-92.
53. Gueyffier F, Bulpitt C, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA group. Lancet 1999; 353: 793-6.
54. Bulpitt CJ, Fletcher AE, Beckett N, et al. The Hypertension in the Very Elderly Trial (HYVET). Protocol for the main trial. Drugs Aging 2001; 18: 151-66.
55. Peters R, Beckett N, Nunes M, et al. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET4COG): An ongoing randomised, double-blind, placebo-controlled trial. Drugs Aging 2006; 23(1): 83-92.
56. Форетт Ф. Насколько польза от гипотензивной терапии у больных старческого возраста превосходит риск? 18-й Конгресс Международного общества по артериальной гипертензии. Чикаго, США 20424.08.2000г.
57. Galarza CR, Alfie J, Waisman GD, et al. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension. 1997; 30 (4): 809-16.
Рецензия
Для цитирования:
Ратова Л.Г., Чазова И.Е. Изолированная систолическая артериальная гипертония. Кардиоваскулярная терапия и профилактика. 2007;6(2):93-104.
For citation:
Ratova L.G., Chazova I.E. Isolated systolic arterial hypertension. Cardiovascular Therapy and Prevention. 2007;6(2):93-104. (In Russ.)